Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Global Strategic Communications:
David Verga

Email: media@path.org

Recent Press Coverage

  1. Dr. Cathy Ndiaye, Director of HPV Vaccine Programs at PATH, shares her personal connection to the fight against cervical cancer and her efforts to address disparities in prevention and care.
    Published: November 2024
  2. Nikolaj Gilbert, President and CEO of PATH, shares insights on the growing trend of global health organizations appointing Chief AI Officers (CAIOs) to harness the transformative potential of artificial intelligence in healthcare.
    Published: September 2024
  3. The first vaccine for malaria received major regulatory approval in 2015. It didn’t become part of vaccination programs in Africa until 2024. PATH's Ashley Birkett speaks about the manufacturing plans that GSK had put in place were derailed.
    Published: July 2024
  4. Neeraj Jain, PATH’s Country Director for India, speaks on the role of technology in revolutionizing health care, improving outcomes, and driving medical research in India.
    Published: June 2024

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

970 Item s
970 Item s
    Date
    From
    To
  1. Published: September 2022
    Press Release
  2. The PATH-led USAID/PEPFAR Serving Life project introduced, scaled, and successfully transitioned an integrated, person-centered package of comprehensive health services in prison and community settings to enhance the delivery of testing and treatment services among key populations in Ukraine.
    Published: September 2022
    Press Release
  3. MedAccess, PATH, and SD Biosensor announce a new partnership aimed at advancing progress towards the elimination of P. vivax malaria. The partnership will increase access to G6PD testing, which provides doctors with essential information to prescribe the safest, most effective course of treatment for P. vivax malaria patients.
    Published: September 2022
    Press Release
  4. Published: September 2022
    Announcement
  5. The vaccine's prequalification is a key step in protecting children and reducing the burden of malaria.
    Published: September 2022
    Announcement